Enable JavaScript to visit this website.

ASPIRE-Sicklecell Apply


To be eligible for an ASPIRE Sickle Cell Disease Research Award, applicants must:
  • Have a medical degree (MD or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
  • Reside and practice in the United States or Canada.
  • Justify the novelty of the proposal, with no direct overlap, if supported by multiple funding sources.

Deadline for Application

  • Full applications must be received by Monday, March 19, 2018, 11:59 PM Pacific Daylight Time.
  • Addenda, supplemental materials, changes, or updates will not be accepted after this deadline.
  • Award decisions will be made and applicants are scheduled to be notified by May 2018.
  • The final study report will be expected within the proposed time after study start.

How to Apply

Applications should be submitted through Pfizer’s Investigator-Initiated Research (INSPIIRE) website. Please click on the “To apply click here” link below and follow the online instructions under “Attention Competitive Grant submitters” (in the bottom right corner). If this is your first time visiting the portal, you must first create an account.

Please select 2018 ASPIRE Sickle Cell Disease Awards from the competitive program dropdown. The system will automatically populate the study title with the correct program ID.

Completed application forms must be accompanied by the following documents:
  • Completed application form (maximum 6 pages not including references) downloaded here
  • Cover letter on institutional letterhead
  • Abbreviated curriculum vitae (CV) for Principal Investigator (NIH biosketch format will be accepted)
  • Relevant articles from the applicant’s scientific publications (if applicable)
  • Itemized Project budget (including overhead, capped at 28%)
  • Bibliography of relevant references
  • Description of available research facilities

To apply click here


Please see the Frequently Asked Questions (FAQ) page for help.

You may also e-mail questions to [email protected]